CA
TNDM icon

Continuum Advisory’s Tandem Diabetes Care TNDM Stock Holding History

Continuum Advisory’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$1.92K – 1461
2025
Q1 		$1.92K Hold
100
– – ﹤0.01% 1359
2024
Q4 		$3.6K Hold
100
– – ﹤0.01% 1221
2024
Q3 		$2.86K Buy
+100
New +$4.24K ﹤0.01% 1313

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Continuum Advisory's TNDM Position: Q2 2025 in Review

Continuum Advisory sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 100 shares — an estimated $1.92K sold.

Continuum Advisory first reported a position in TNDM in Q3 2024 and held it in 3 quarters. The position peaked at $3.6K in Q4 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Continuum Advisory reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 100 Tandem Diabetes Care shares in Q2 2025, an estimated $1.92K.
  • Continuum Advisory first reported a position in Tandem Diabetes Care in Q3 2024 and held it in 3 quarters.
  • Continuum Advisory's Tandem Diabetes Care position peaked at $3.6K in Q4 2024.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.